Range
12.38 - 13.33
Vol / Avg.
7K/200.3K
Div / Yield
-
52 Wk
12.69 - 37.51
Mkt Cap
554.9M
Payout Ratio
-
Open
13.27
P/E
-
EPS
-0.78
Shares
42.6M
Outstanding
42.6M
Total Float
19.1M
load more
Sector: Health Care.Industry: Biotechnology
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.810-0.780 0.0300
REV1.537M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aligos Therapeutics Questions & Anwsers

Q

How do I buy Aligos Therapeutics (ALGS) stock?

A

You can purchase shares of Aligos Therapeutics (NASDAQ: ALGS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aligos Therapeutics's (ALGS) competitors?

Q

What is the target price for Aligos Therapeutics (ALGS) stock?

A

The latest price target for Aligos Therapeutics (NASDAQ: ALGS) was reported by SVB Leerink on September 9, 2021. The analyst firm set a price target for 29.00 expecting ALGS to rise to within 12 months (a possible 122.73% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aligos Therapeutics (ALGS)?

A

The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $13.02 last updated Today at 3:21:08 PM.

Q

Does Aligos Therapeutics (ALGS) pay a dividend?

A

There are no upcoming dividends for Aligos Therapeutics.

Q

When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?

A

Aligos Therapeutics’s $Q3 earnings are confirmed for after-market on November 4, 2021.

Q

Is Aligos Therapeutics (ALGS) going to split?

A

There is no upcoming split for Aligos Therapeutics.

Q

What sector and industry does Aligos Therapeutics (ALGS) operate in?

A

Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.